Table 4.
Variables | DFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.305 | 0.516–3.301 | 0.573 | 0.548 | 0.199–1.511 | 0.245 |
Gender | 0.511 | 0.196–1.332 | 0.169 | 0.559 | 0.200–1.560 | 0.267 |
Location | 0.687 | 0.258–1.834 | 0.454 | 0.688 | 0.241–1.965 | 0.485 |
TNM stage | 1.692 | 0.572–5.008 | 0.342 | 2.382 | 0.787–7.208 | 0.124 |
T stage | 2.117 | 0.957–4.682 | 0.064 | 2.940 | 1.224–7.063 | 0.016* |
N stage | 0.654 | 0.153–2.799 | 0.568 | 8.891 | 0.959–82.455 | 0.054 |
Metastatic sites | 3.228 | 1.306–7.977 | 0.011* | 0.728 | 0.246–2.154 | 0.566 |
NLR | 3.425 | 1.223–9.593 | 0.019* | 3.384 | 1.066–10.741 | 0.039* |
CTC | 2.841 | 0.594–13.598 | 0.191 | 4.800 | 0.562–41.009 | 0.152 |
*P < 0.05; HR, Hazard ratio; CI, Confidence interval; DFS, Disease-free survival; OS, overall survival.